Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms

American Journal of Surgical Pathology

Volumn 31, Issue 7, 2007, Pages 1038-1044

  Nonaka, Daisuke ^a,c   Henley, John D ^b   Chiriboga, Luis ^a   Yee, Herman ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CD205; DEC205; Foxn1; Thymic carcinoma; Thymoma

Indexed keywords

BIOLOGICAL MARKER; CD205 PROTEIN; FOXN1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BONE MARROW CELL; DENDRITIC CELL; ESOPHAGUS CARCINOMA; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; NEUROENDOCRINE TUMOR; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; THYMOMA; THYMUS CANCER; TISSUE MICROARRAY; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SQUAMOUS CELL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOENZYME TECHNIQUES; LECTINS, C-TYPE; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; THYMOMA; THYMUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34347358583     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31802b4917     Document Type: Article

References (24)

1. Barisella M, Andreola S, Rosai J. CD117 in soft tissue sarcomas. Am J Clin Pathol. 2002;118:470-471.
2. Berezowski K, Grimes MM, Gal A, et al. CD5 immunoreactivity of epithelial cells in thymic carcinoma and CASTLE using paraffin-embedded tissue. Am J Clin Pathol. 1996;106:483-486.
3. Boskovic J, Arnold JN, Stilion R, et al. Structural model for the mannose receptor family uncovered by electron microscopy of Endo180 and the mannose receptor. J Biol Chem. 2006;281:8780-8787.
4. Dorfman DM, Shahsafaei A, Chan JK. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am J Surg Pathol. 1997;21:936-940.
5. Gliddon DR, Hope JC, Brooke GP, et al. DEC-205 expression on migrating dendritic cells in afferent lymph. Immunology. 2004;111:262-272.
6. Henley JD, Cummings OW, Loehrer PJ Sr. Tyrosine kinase receptor expression in thymomas. J Cancer Res Clin Oncol. 2004;130:222-224.
7. Hishima T, Fukayama M, Fujisawa M, et al. CD5 expression in thymic carcinoma. Am J Pathol. 1994;145:268-275.
8. Hishima T, Fukayama M, Hayashi Y, et al. CD70 expression in thymic carcinoma. Am J Surg Pathol. 2000;24:742-746.
9. Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol. 2001;158:1245-1251.
10. Hornick JL, Fletcher CD. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol. 2002;117:188-193.
11. Jiang W, Swiggard WJ, Heufler C, et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature. 1995;375:151-155.
12. Junker K, Hindermann W, von Eggeling F, et al. CD70: a new tumor specific biomarker for renal cell carcinoma. J Urol. 2005;173:2150-2153.
13. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847.
14. Kornstein MJ, Rosai J. CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms. Am J Clin Pathol. 1998;109:722-726.
15. Manley NR, Blackburn CC. A developmental look at thymus organogenesis: where do the non-hematopoietic cells in the thymus come from? Curr Opin Immunol. 2003;15:225-232.
16. Mecklenburg L, Tychsen B, Paus R. Learning from nudity: lessons from the nude phenotype. Exp Dermatol. 2005;14:797-810.
17. Moran CA, Suster S. Thymoma with prominent cystic and hemorrhagic changes and areas of necrosis and infarction: a clinicopathologic study of 25 cases. Am J Surg Pathol. 2001;25:1086-1090.
18. Müller-Hermelink HK, Engel P, Kuo TT, et al. Tumours of the thymus. In: Travis WD, Brambilla E, Müller-Hermelink HK, et al. eds. Pathology & Genetics, Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004:145-247.
19. Nakagawa K, Matsuno Y, Kunitoh H, et al. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest. 2005;128:140-144.
20. Pan CC, Chen PC, Chiang H. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. J Pathol. 2004;202:375-381.
21. Rosai J. Histological Typing of Tumours of the Thymus. Berlin: Springer-Verlag; 1999.
22. Shimosato Y, Kameya T, Nagai K, et al. Squamous cell carcinoma of the thymus. An analysis of eight cases. Am J Surg Pathol. 1977;1:109-121.
23. Small M, Kraal G. In vitro evidence for participation of DEC-205 expressed by thymic cortical epithelial cells in clearance of apoptotic thymocytes. Int Immunol. 2003;15:197-203.
24. Tateyama H, Eimoto T, Tada T, et al. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma. Am J Clin Pathol. 1999;111:235-240.